Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

Condition:   Pandemic H5N1 InfluenzaIntervention:   Biological: Adjuvanted H5N1 pandemic influenza vaccineSponsors:   Novartis Vaccines;   Department of Health and Human ServicesCompleted - verified January 2015

Source: ClinicalTrials.gov - January 20, 2013 Category: Research Source Type: clinical trials